Avenue Therapeutics Inc ATXI
$0.42 $0.43 (50.71%) 1D
Last Updated: Mar 18, 12:00 AM·OOTC
Pricing for US stocks is delayed by 24 hours
ATXI Shariah Compliance
Screening Methodology: AAOIFI
As of August 2026, Avenue Therapeutics Inc is classified as not halal.
NOT HALAL
Report Source: undefined Quarter Report
Avenue Therapeutics Inc. Stock Analysis ATXI
United States Health Care Nano Cap Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. The company is headquartered in Bay Harbor Islands, Florida and currently employs 1 full-time employees. The company went IPO on 2017-06-27. The firm is focused on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidate, intravenous tramadol (IV tramadol) is a novel therapy in development in the United States for managing post-operative pain as an alternative to conventional narcotics. The drug is designed to use a dual mechanism of action to block a patient’s pain signal with reduced abuse potential. This unique mechanism of action includes an opioid agonist and an inhibitor of norepinephrine and serotonin re-uptake.
Avenue Therapeutics Inc (ATXI) Chart
Financial Metrics & Statements of Avenue Therapeutics Inc (ATXI)
FAQ's for Avenue Therapeutics Inc (ATXI)
- As of August 2026, Avenue Therapeutics Inc ATXI is classified as not halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Avenue Therapeutics Inc using these criteria to determine its compliance status.
- Muslim investors may consider investing in Avenue Therapeutics Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Avenue Therapeutics Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Avenue Therapeutics Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Avenue Therapeutics Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.
Alternate Halal Stocks for Avenue Therapeutics Inc (ATXI)
Related Halal Stocks are Shariah-compliant companies that align with Islamic investment principles, avoiding prohibited industries like alcohol, gambling, and interest-based finance.
